探讨"热疗联合长效抗菌材料"治疗生殖道高危型人乳头瘤病毒(HPV)感染的有效性及可行性。

选择2009年1月至2010年12月南通市肿瘤医院收治的182例宫颈癌治愈后生殖道高危型HPV检查仍呈阳性并接受转阴治疗的患者为研究对象。将其按照治疗方法的不同分为3组：热疗+ 长效抗菌材料组(n =60)，长效抗菌材料治疗组(n = 56)及热疗组(n=66)。3组病例治疗频率均为2次/d，治疗7 d为一个疗程。1个月后检测生殖道高危性HPV有无转阴。选择未接受转阴治疗并愿意随访观察的患者（宫颈癌治愈后生殖道高危型HPV仍呈阳性）为对照组(n = 72)，定期随访一年，观察自然转阴率（本研究遵循的程序符合南通市肿瘤医院人体试验委员会制定的伦理学标准，得到该委员会批准，征得受试对象知情同意，并与之签署临床研究知情同意书）。各组患者年龄、KPS功能状态评分（可评定对抗肿瘤治疗的耐受力）等一般情况比较，差异无统计学意义(P>0. 05)。

高危性HPV转阴率分别为：热疗+ 长效抗菌材料组(85.0%)，长效抗菌材料治疗组(46.4%)，热疗组(24.2%)，对照组(8.3%)。接受转阴治疗的3组间HPV转阴率比较，差异有统计学意义(P<0. 005)，热疗+长效抗菌材料组转阴率明显高于另两组。治疗组与对照组HPV转阴率比较，差异有统计学意义(P<0.005)。

"热疗联合长效抗菌材料"能更有效的治疗生殖道高危型HPV感染。

To explore the efficacy and feasibility of "hyperthermia combined with long-lasting antibacterial materials" in treatment of high-risk HPV infection in genital tract.

182 cases with high-risk HPV infection in genital tract after cervical cancer cure from January 2009 to December 2010 in our hospital were randomly divided into three groups: group of hyperthermia combined with long-lasting antibacterial materials (n = 60); group of long-lasting antibacterial materials (n = 56) and group of hyperthermia(n = 66). All cases were treated twice a day per week and the darkening was detected after one month. The control group (n=72) who were not treated as above and will to follow up for one year and the natural negative rate was observed. The study protocol was approved by the Ethical Review Board of Investigation in Human Beings of Tumor Hospital of Nantong University. Informed consent was obtained from each participating patient. The general data such as patients' age, KPS function score had no significant difference(P>0. 05).

The darkening of combined treatment group was 85. 0% , much higher than 46. 4% of antibacterial materials group and 24. 2% of hyperthermia group, while the darkening of the control group was only 8. 3 The difference was significant (P< 0. 005). Comparison of overcast rate between therapy group and control group had significant difference ( P<0. 005).

"Hyperthermia combined with long-lasting antibacterial materials" in treatment of high-risk HPV infection in genital tract is more effective.